Associate Professor
Brigham and Women's Hospital
Disclosure: Allovir (Consultant)Amplyx (Consultant)Ansun (Scientific Research Study Investigator)Avir (Consultant)Cidara (Scientific Research Study Investigator)F2G (Consultant, Scientific Research Study Investigator)Kyorin (Consultant)Merck (Consultant, Grant/Research Support, Scientific Research Study Investigator)New England Journal of Medicine (Other Financial or Material Support, Honorarium for Video)Regeneron (Consultant, Scientific Research Study Investigator)ReViral (Consultant)Scynexis (Scientific Research Study Investigator)Symbio (Consultant)Takeda (Scientific Research Study Investigator)United Medical (Consultant)WHISCON (Scientific Research Study Investigator)
Dr. Marty is Associate Professor of Medicine at Harvard Medical School and attending physician at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Transplant and Oncology Infectious Diseases.
Dr. Marty’s research interests include the clinical epidemiology of infectious diseases in diverse transplant and cancer populations, the development and validation of novel infectious disease diagnostics in immunocompromised hosts, and the conduct of clinical trials for investigational anti-infectives of particular relevance to these populations. He is editor-in-chief of the Transplant Infectious Disease journal.
Dr. Marty received his MD degree from Universidad Central de Venezuela, did his residency in internal medicine at Albert Einstein College of Medicine –where he served as chief resident–, and his fellowship in infectious diseases at the Brigham and Women’s Hospital and Massachusetts General Hospital combined program. He has a Master in Science in Clinical Epidemiology from the Harvard School of Public Health and is a Fellow of the American College of Medicine and the Infectious Diseases Society of America.
